| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.06 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |